Sinovac Costs More But Is Less Effective Than Other Vaccines According to Data
SINOVAC VACCINE LESS EFFECTIVE – China’s leading COVID-19 vaccine, Sinovac, was found to have a 50% efficacy rate but costs more than other vaccines.
As 2021 comes to a close, several vaccine candidates against COVID-19 were developed. Among the leading brands were Pfizer and Moderna’s COVID-19 vaccines.
However, the Philippines’ Vaccine Czar emphasized that the government was prioritizing China’s Sinovac Vaccine which had a 50% efficacy rate. According to the DOST, this was acceptable as it passed the World Health Organizations’ minimum requirements.
Still, with such a low efficacy rating, Sinovac is still the second-most expensive vaccine next to Moderna which showed 95% effectiveness against COVID-19.
According to an article from ABS-CBN, here are the estimated prices of vaccines inclusive of 12% vat, 10% inflation rate:
|Vaccine||Doses||Total Price (inclusive of 12% vat, 10% inflation rate)||Efficacy Rate|
# Of Recipients (For P82.5B)
|Moderna||2||3,904-4,504||94%||18,317,051 – 21,132,172|
Thanks for reading. We aim to provide our readers with the freshest and most in-demand content. Come back next time for the latest news here on Philnews.
What do you think about this? Leave a comment below!